A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization.

Saved in:
Bibliographic Details
Title: A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization.
Authors: Chen J; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia., Lin FL; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.; Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China., Leung JYK; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia., Tu L; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Wang JH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia., Chuang YF; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia., Li F; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong, China., Shen HH; Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia.; Department of Biochemistry and Molecular Biology, School of Biomedical Science, Monash University, Clayton, VIC, Australia., Dusting GJ; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia., Wong VHY; Department of Optometry and Vision Sciences, University of Melbourne, Parkville, VIC, Australia., Lisowski L; Translational Vectorology Group, Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Vector and Genome Engineering Facility, Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Military Institute of Hygiene and Epidemiology, The Biological Threats Identification and Countermeasure Centre, Puławy, Poland., Hewitt AW; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia., Bui BV; Department of Optometry and Vision Sciences, University of Melbourne, Parkville, VIC, Australia., Zhong J; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Liu GS; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China. rickliu0817@gmail.com.; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia. rickliu0817@gmail.com.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia. rickliu0817@gmail.com.
Source: Angiogenesis [Angiogenesis] 2021 Feb; Vol. 24 (1), pp. 97-110. Date of Electronic Publication: 2020 Sep 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 9814575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7209 (Electronic) Linking ISSN: 09696970 NLM ISO Abbreviation: Angiogenesis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7209
DOI:10.1007/s10456-020-09745-7